InvestorsHub Logo
Followers 106
Posts 2388
Boards Moderated 0
Alias Born 11/02/2016

Re: None

Friday, 11/03/2017 3:40:11 PM

Friday, November 03, 2017 3:40:11 PM

Post# of 54143
DAVID N. FELDMAN
Partner
Duane Morris LLP
1540 Broadway
New York, NY 10036-4086
USA Phone: +1 212 692 1036
Fax: +1 212 202 6094
dnfeldman@duanemorris.com


Assisted Surna Inc. in completing a $2,685,000 private placement of investment units, each unit consisting of one share of common stock and a warrant to purchase one share of common stock.
Assisted The Lovesac Company, a furniture retailer specializing in patented modular furniture systems, in successfully completing a multi-million dollar private placement of preferred stock and warrants to various funds and private investors.
Represented Myomo Inc. in its historic initial public offering, raising an aggregate of approximately $8 million in the IPO and a contemporaneous private offering of investment units. Myomo became the first company to list its stock on a national securities exchange upon completion of an IPO under SEC Regulation A+ under the Jumpstart Our Business Startups (JOBS) Act of 2012.
Assisted Zeta Acquisition Corp. II in its merger and change of control transaction with Aerpio Therapeutics.
Represented Double Down Asset Management, LLC in its $1.8 million investment in Step Ahead Innovations, LLC, doing business as MindStream, consisting of common and preferred stock.
Represented public issuer Minn Shares, Inc. in its change of control transaction with Titan CNG LLC.
Represented GreenKissNY, Inc. in its $3 million initial public offering under SEC Regulation A+.
Represented GreenKissNY Inc. in connection with its $2 million private placement of equity securities.
Represented Phoenix Color Corp. in sale of company to Visant Corp. for $219 million.
Represented VirnetX Inc. in its going public transaction. It later settled a patent claim with Microsoft for more than $200 million.
Represented MetSchools and affiliates in the sale of the Claremont School in Manhattan to Meritas LLC.
Represented Protea Biosciences Inc. in its going public transaction in 2011 and multiple additional financings through 2014 totaling approximately $20 million.
Represented Eastern Air Lines Group Inc. in $2.5 million private placement.
Represented shell in reverse merger of Intra-Cellular Therapies, Inc., now with a $1 billion market cap.

Represented DFA Intercultural Worldwide LLC in its sale to Dwellworks LLC.
Represented Vertical Lend Inc. in its sale to Upright Holdings Inc.
Represented Sunrise Securities Corp. as underwriter for public offering of $12 million by Liqtech International Inc.
Represented MetSchools, Inc in the offering of up to $6 million in notes.

Represented investment bank in going public transaction of pharmaceutical company and related financing of approximately $5 million.
Represented Livewire Mobile, Inc. in its acquisition of FoneStarz Medial Group Limited.
Represented DanDrit Biotechnology Corp. in its going public transaction and $6 million public offering thereafter.
Represented Leviathan Minerals Group, Inc. in its going public transaction and related $5 million offering of securities through Northland Securities Inc. as placement agent.
Represented Splinternet Holdings, Inc. (now Defentect Group Inc.) in going public through "self-filing" process.
Represented investment bank in $5 million private offering for international mining company.
Represented Lane Capital Markets LLC in $3 million offering by A&P OptMed Partners I, LLC to invest in OptMed Inc
.
Represented Biocontrol Ltd. in going public transaction with AmpliPhi Biosciences (formerly Targeted Genetics), a public operating company.
Represented JDF Capital LLC in approximately 12 investments in convertible notes issued by public companies in amounts up to $500,000 each.
Represented supermodel Carol Alt in endorsement deal for nutritional supplement with an equity ownership in the business.
Represented shell in going public transaction of Cougar Biotechnology, later sold for approximately $1 billion.
Represented public vehicle in going public transaction of Puma Biotechnology.
Represented public vehicle in going public transaction of Emmaus Medical Inc.
Created, took public and handled periodic SEC filings on behalf of approximately 200 Form 10 public vehicle companies between 2005 and 2015.

My posts are my personal opinion, DD, or thoughts that hopefully add value to the conversation.